EGF Theramed Health Corp.
TMED
CNSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -71.19% | 99.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -71.19% | 99.23% | |||
| Operating Income | 71.19% | -99.23% | |||
| Income Before Tax | 97.02% | -2,761.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 97.87% | -3,908.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 363.64% | -194.29% | |||
| Net Income | 98.29% | -4,202.67% | |||
| EBIT | 71.19% | -99.23% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 98.28% | -4,195.24% | |||
| Normalized Basic EPS | 98.07% | -3,220.00% | |||
| EPS Diluted | 98.28% | -4,195.24% | |||
| Normalized Diluted EPS | 98.07% | -3,220.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||